Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2022
Q2
Sell
-27
Closed -$25K 3905
2022
Q1
$25K Hold
27
﹤0.01% 3897
2021
Q4
$51K Sell
27
-18
-40% -$42.8K ﹤0.01% 3901
2021
Q3
$142K Sell
45
-16
-26% -$50K ﹤0.01% 3747
2021
Q2
$197K Buy
+61
New +$276K ﹤0.01% 3761
2018
Q2
Sell
-17
Closed -$22K 3648
2018
Q1
$22K Hold
17
﹤0.01% 3604
2017
Q4
$24K Sell
17
-4
-19% -$9.41K ﹤0.01% 3614
2017
Q3
$64K Sell
21
-137
-87% -$506K ﹤0.01% 3627
2017
Q2
$599K Sell
158
-80
-34% -$334K ﹤0.01% 3165
2017
Q1
$1.32M Sell
238
-14
-6% -$77.8K ﹤0.01% 2759
2016
Q4
$1.55M Sell
252
-2
-0.8% -$12K ﹤0.01% 2750
2016
Q3
$1.32M Buy
254
+4
+2% +$14.7K ﹤0.01% 2791
2016
Q2
$781K Sell
250
-198
-44% -$707K ﹤0.01% 2990
2016
Q1
$1.44M Sell
448
-465
-51% -$1.56M ﹤0.01% 2688
2015
Q4
$5.31M Sell
913
-12
-1% -$58.6K ﹤0.01% 1973
2015
Q3
$3.74M Buy
925
+321
+53% +$1.82M ﹤0.01% 2207
2015
Q2
$4M Buy
604
+145
+32% +$871K ﹤0.01% 2301
2015
Q1
$2.2M Buy
459
+423
+1,175% +$2.04M ﹤0.01% 2549
2014
Q4
$115K Buy
36
+2
+6% +$5.26K ﹤0.01% 3576
2014
Q3
$96K Buy
34
+27
+386% +$90.8K ﹤0.01% 3692
2014
Q2
$28K Buy
+7
New +$28.5K ﹤0.01% 4165
2014
Q1
Hold
0
5165
2013
Q4
Sell
-3
Closed -$20.6K 4981
2013
Q3
$26K Hold
3
﹤0.01% 4233
2013
Q2
$19K Buy
+3
New +$21.2K ﹤0.01% 4306

Other funds holding CRIS

Ameriprise's CRIS Position: Q2 2022 in Review

Ameriprise sold out of Curis (CRIS) in Q2 2022, closing a stake of 27 shares — an estimated $25K sold.

Ameriprise first reported a position in CRIS in Q2 2013 and held it in 22 quarters. The position peaked at $5.31M in Q4 2015. 86 funds tracked by Wall St. Rank hold CRIS as of Q2 2022.

  • Ameriprise reported no remaining Curis position as of Q2 2022 after selling out during the quarter.
  • Ameriprise sold 27 Curis shares in Q2 2022, an estimated $25K.
  • Ameriprise first reported a position in Curis in Q2 2013 and held it in 22 quarters.
  • Ameriprise's Curis position peaked at $5.31M in Q4 2015.
  • 86 funds tracked by Wall St. Rank held Curis as of Q2 2022.

Based on Ameriprise's 13F filing for Q2 2022, filed 15 Aug 2022.